renin-angiotensin-aldosterone system inhibitors

First patient enrolled in CARE-HK in HF to evaluate role of Veltassa® (patiromer) in enabling RAASi treatment

CARE-HK in heart failure (HF) is the first global registry of around 5,000 patients with chronic HF who have or…

Read More »